Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries

Luke C Mullany, Gary L. Darmstadt, James M. Tielsch

Research output: Contribution to journalArticle

Abstract

Affordable, efficacious, and safe interventions to prevent infections and improve neonatal survival in low-resource settings are needed. Chlorhexidine is a broad-spectrum antiseptic that has been used extensively for many decades in hospital and other clinical settings. It has also been given as maternal vaginal lavage, full-body newborn skin cleansing, and/or umbilical cord cleansing to prevent infection in neonates. Recent evidence suggests that these chlorhexidine interventions may have significant public health impact on the burden of neonatal infection and mortality in developing countries. This review examines the available data from randomized and nonrandomized studies of chlorhexidine cleansing, with a primary focus on potential uses in low-resource settings. Safety issues related to chlorhexidine use in newborns are reviewed, and future research priorities for chlorhexidine interventions for neonatal health in developing countries are discussed.We conclude that maternal vaginal cleansing combined with newborn skin cleansing could reduce neonatal infections and mortality in hospitals of sub-Saharan Africa, but the individual impact of these interventions must be determined, particularly in community settings. There is evidence for a protective benefit of newborn skin and umbilical cord cleansing with chlorhexidine in the community in south Asia. Effectiveness trials in that region are required to address the feasibility of community-based delivery methods such as incorporating these interventions into clean birth kits or training programs for minimally skilled delivery assistants or family members. Efficacy trials for all chlorhexidine interventions are needed in low-resource settings in Africa, and the benefit of maternal vaginal cleansing beyond that provided by newborn skin cleansing needs to be determined.

Original languageEnglish (US)
Pages (from-to)665-675
Number of pages11
JournalPediatric Infectious Disease Journal
Volume25
Issue number8
DOIs
StatePublished - Aug 2006

Fingerprint

Antisepsis
Chlorhexidine
Developing Countries
Safety
Newborn Infant
Skin
Umbilical Cord
Mothers
Infant Mortality
Infection
Vaginal Douching
Local Anti-Infective Agents
Africa South of the Sahara
Infant Health
Public Health
Parturition
Education

Keywords

  • Chlorhexidine
  • Cleansing
  • Infection
  • Mortality
  • Neonatal
  • Omphalitis
  • Skin infection
  • Superficial infection
  • Umbilical cord

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Cite this

Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. / Mullany, Luke C; Darmstadt, Gary L.; Tielsch, James M.

In: Pediatric Infectious Disease Journal, Vol. 25, No. 8, 08.2006, p. 665-675.

Research output: Contribution to journalArticle

@article{94129f9aeccf4d1987f44e461526a21e,
title = "Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries",
abstract = "Affordable, efficacious, and safe interventions to prevent infections and improve neonatal survival in low-resource settings are needed. Chlorhexidine is a broad-spectrum antiseptic that has been used extensively for many decades in hospital and other clinical settings. It has also been given as maternal vaginal lavage, full-body newborn skin cleansing, and/or umbilical cord cleansing to prevent infection in neonates. Recent evidence suggests that these chlorhexidine interventions may have significant public health impact on the burden of neonatal infection and mortality in developing countries. This review examines the available data from randomized and nonrandomized studies of chlorhexidine cleansing, with a primary focus on potential uses in low-resource settings. Safety issues related to chlorhexidine use in newborns are reviewed, and future research priorities for chlorhexidine interventions for neonatal health in developing countries are discussed.We conclude that maternal vaginal cleansing combined with newborn skin cleansing could reduce neonatal infections and mortality in hospitals of sub-Saharan Africa, but the individual impact of these interventions must be determined, particularly in community settings. There is evidence for a protective benefit of newborn skin and umbilical cord cleansing with chlorhexidine in the community in south Asia. Effectiveness trials in that region are required to address the feasibility of community-based delivery methods such as incorporating these interventions into clean birth kits or training programs for minimally skilled delivery assistants or family members. Efficacy trials for all chlorhexidine interventions are needed in low-resource settings in Africa, and the benefit of maternal vaginal cleansing beyond that provided by newborn skin cleansing needs to be determined.",
keywords = "Chlorhexidine, Cleansing, Infection, Mortality, Neonatal, Omphalitis, Skin infection, Superficial infection, Umbilical cord",
author = "Mullany, {Luke C} and Darmstadt, {Gary L.} and Tielsch, {James M.}",
year = "2006",
month = "8",
doi = "10.1097/01.inf.0000223489.02791.70",
language = "English (US)",
volume = "25",
pages = "665--675",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries

AU - Mullany, Luke C

AU - Darmstadt, Gary L.

AU - Tielsch, James M.

PY - 2006/8

Y1 - 2006/8

N2 - Affordable, efficacious, and safe interventions to prevent infections and improve neonatal survival in low-resource settings are needed. Chlorhexidine is a broad-spectrum antiseptic that has been used extensively for many decades in hospital and other clinical settings. It has also been given as maternal vaginal lavage, full-body newborn skin cleansing, and/or umbilical cord cleansing to prevent infection in neonates. Recent evidence suggests that these chlorhexidine interventions may have significant public health impact on the burden of neonatal infection and mortality in developing countries. This review examines the available data from randomized and nonrandomized studies of chlorhexidine cleansing, with a primary focus on potential uses in low-resource settings. Safety issues related to chlorhexidine use in newborns are reviewed, and future research priorities for chlorhexidine interventions for neonatal health in developing countries are discussed.We conclude that maternal vaginal cleansing combined with newborn skin cleansing could reduce neonatal infections and mortality in hospitals of sub-Saharan Africa, but the individual impact of these interventions must be determined, particularly in community settings. There is evidence for a protective benefit of newborn skin and umbilical cord cleansing with chlorhexidine in the community in south Asia. Effectiveness trials in that region are required to address the feasibility of community-based delivery methods such as incorporating these interventions into clean birth kits or training programs for minimally skilled delivery assistants or family members. Efficacy trials for all chlorhexidine interventions are needed in low-resource settings in Africa, and the benefit of maternal vaginal cleansing beyond that provided by newborn skin cleansing needs to be determined.

AB - Affordable, efficacious, and safe interventions to prevent infections and improve neonatal survival in low-resource settings are needed. Chlorhexidine is a broad-spectrum antiseptic that has been used extensively for many decades in hospital and other clinical settings. It has also been given as maternal vaginal lavage, full-body newborn skin cleansing, and/or umbilical cord cleansing to prevent infection in neonates. Recent evidence suggests that these chlorhexidine interventions may have significant public health impact on the burden of neonatal infection and mortality in developing countries. This review examines the available data from randomized and nonrandomized studies of chlorhexidine cleansing, with a primary focus on potential uses in low-resource settings. Safety issues related to chlorhexidine use in newborns are reviewed, and future research priorities for chlorhexidine interventions for neonatal health in developing countries are discussed.We conclude that maternal vaginal cleansing combined with newborn skin cleansing could reduce neonatal infections and mortality in hospitals of sub-Saharan Africa, but the individual impact of these interventions must be determined, particularly in community settings. There is evidence for a protective benefit of newborn skin and umbilical cord cleansing with chlorhexidine in the community in south Asia. Effectiveness trials in that region are required to address the feasibility of community-based delivery methods such as incorporating these interventions into clean birth kits or training programs for minimally skilled delivery assistants or family members. Efficacy trials for all chlorhexidine interventions are needed in low-resource settings in Africa, and the benefit of maternal vaginal cleansing beyond that provided by newborn skin cleansing needs to be determined.

KW - Chlorhexidine

KW - Cleansing

KW - Infection

KW - Mortality

KW - Neonatal

KW - Omphalitis

KW - Skin infection

KW - Superficial infection

KW - Umbilical cord

UR - http://www.scopus.com/inward/record.url?scp=33746743078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746743078&partnerID=8YFLogxK

U2 - 10.1097/01.inf.0000223489.02791.70

DO - 10.1097/01.inf.0000223489.02791.70

M3 - Article

C2 - 16874163

AN - SCOPUS:33746743078

VL - 25

SP - 665

EP - 675

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 8

ER -